Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES (via PR Newswire)
DURHAM, N.C., Oct. 23, 2012 /PRNewswire/ — Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut drug-eluting stent distinguished by a rapid-absorbing…
published: October 29, 2012 in: Cardio, Clinical Studies/Trials, Congresses and Meetings